explore -WSS

explore

author：entertainment 2025-08-26 10:52:47 - browse：55

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

WSS

How redistricting in 6 states could affect who controls Congress

Study gives hint on South Asians’ higher risk of cardiovascular disease

Juul documents reveal insider tactics on political lobbying

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Congress considering partial increase for doctor pay in Medicare

focus

explore

knowledge

Apple is now the first public company to be valued at $3 trillion

Report cites 'urgent' need to recruit more diverse clinical trial participants

Virginia high school admissions case could be legal follow

Drinking water from half of US faucets contains PFAS: Study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Drinking water from half of US faucets contains PFAS: Study

In age of alternative facts, a scholarly course on calling out crap

With fresh data, a dynamic duo powers Eli Lilly to new heights

At least 13 dead in Texas as scorching temps continue

Sen. Bill Cassidy on how to lower drug prices

Wikipedia

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Neutralizing antibodies against HIV shows promise in children

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Congress must protect the remaining independent doctors

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Wikipedia

hotspot

Wikipedia

hotspot